Novo Nordisk shares pop 10% on early-stage weight loss drug trial results By: CNBC.com News January 24, 2025 at 06:02 AM EST The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug. Read More >>